SLEEPBIOTICS

Serial Number 90801832
606

Registration Progress

Application Filed
Jun 29, 2021
Under Examination
Jul 28, 2022
Approved for Publication
May 31, 2022
Published for Opposition
May 31, 2022
Registered

Basic Information

Serial Number
90801832
Deadline
August 30, 2025
Description
Trademark Application Revival Due
Filing Date
June 29, 2021
Published for Opposition
May 31, 2022
Abandonment Date
June 30, 2025
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Jun 30, 2025
Classes
005

Rights Holder

BIOHM HEALTH INC.

03
Address
SUITE 100
425 LITERARY RD.
CLEVELAND, OH 44113

Ownership History

Biohm Health LLC

Original Applicant
16
Cleveland, OH

Biohm Health LLC

Owner at Publication
16
Cleveland, OH

BIOHM HEALTH INC.

New Owner After Publication #1
03
CLEVELAND, OH

Legal Representation

Attorney
Brian E. Turung
USPTO Deadlines 1 active 1 overdue
Deadline Type Event Code Deadline Date Days Until Priority Extension Available
OPPOSITION
Notice of Publication
NPUBE Jun 30, 2022 1103 days overdue Medium Until Jul 30, 2022

Application History

40 events
Date Code Type Description
Jun 30, 2025 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Jun 30, 2025 ABN6 S ABANDONMENT - NO USE STATEMENT FILED
Dec 13, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 13, 2024 EX4G S SOU EXTENSION 4 GRANTED
Nov 27, 2024 EXT4 S SOU EXTENSION 4 FILED
Nov 27, 2024 EEXT I SOU TEAS EXTENSION RECEIVED
Oct 2, 2024 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL
Oct 2, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 2, 2024 EX3G S SOU EXTENSION 3 GRANTED
Jul 15, 2024 NREV E NOTICE OF REVIVAL - E-MAILED
Jul 15, 2024 APET A ASSIGNED TO PETITION STAFF
Jul 15, 2024 PGEX O PETITION GRANTED - EXTENSION REQUEST FILED
May 30, 2024 PROA I TEAS PETITION TO REVIVE RECEIVED
May 30, 2024 PROA I TEAS PETITION TO REVIVE RECEIVED
May 29, 2024 EXT3 S SOU EXTENSION 3 FILED
Nov 29, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 28, 2023 EX2G S SOU EXTENSION 2 GRANTED
Nov 28, 2023 EXT2 S SOU EXTENSION 2 FILED
Nov 28, 2023 EEXT I SOU TEAS EXTENSION RECEIVED
Jun 1, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 30, 2023 EX1G S SOU EXTENSION 1 GRANTED
May 30, 2023 EXT1 S SOU EXTENSION 1 FILED
May 30, 2023 EEXT I SOU TEAS EXTENSION RECEIVED
Apr 19, 2023 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Nov 29, 2022 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Oct 17, 2022 NEWN I NEW NOA TO ISSUE
Jul 28, 2022 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jul 26, 2022 IUCN S NOTICE OF ALLOWANCE CANCELLED
May 31, 2022 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 31, 2022 PUBO A PUBLISHED FOR OPPOSITION
May 11, 2022 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 25, 2022 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 22, 2022 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 21, 2022 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 21, 2022 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 12, 2022 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 12, 2022 GNRT F NON-FINAL ACTION E-MAILED
Jan 12, 2022 CNRT R NON-FINAL ACTION WRITTEN
Jan 10, 2022 DOCK D ASSIGNED TO EXAMINER
Sep 11, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Detailed Classifications

Class 005
Probiotic supplements; vitamin and mineral supplements; vitamin supplements; whey protein supplements; dietary supplement drink mixes; dietary supplement for eliminating toxins from the intestinal tract; enzyme food supplements; herbal supplements; mineral supplements; multi-vitamin preparations; natural herbal supplements; nutraceuticals for use as a dietary supplement; nutritional supplement for eliminating toxins from the intestinal tract; nutritional supplement shakes; nutritional supplements, namely, probiotic compositions; nutritional supplements, namely, carbohydrates in powdered form; powdered nutritional supplement concentrate; vitamin and mineral supplements in powder, tablet, liquid, capsule or spray form; mineral supplements in powder, tablet, liquid, capsule or spray form; dietary supplements in powder, tablet, liquid, capsule or spray form; food supplements providing a source of vitamins and minerals and essential fatty acids and probiotic cultures in powder, tablet, liquid, capsule or spray form; nutritional supplements for human consumption providing a source of vitamins and minerals and essential fatty acids and probiotic cultures in powder, tablet, liquid, capsule or spray form; herbal supplements for general health and well-being, namely, in powder, tablet, liquid, capsule or spray form; nutritional supplements, namely, probiotic compositions in the nature of a vaginal probiotic for the treatment and prevention of bacterial and fungal vaginal infection; nutraceuticals for the treatment and prevention of bacterial vaginosis, vaginal discharge and odors, for preventing the growth of undesirable micro-organisms that can cause vaginal discharge and odor, killing bacteria that cause bacterial vaginosis, and for maintaining a desirable microflora in the vaginal cavity; micro-organisms culture for medical use, namely, lactic acid bacteria and bifidobacteria having probiotic activity on humans for the treatment of diseases, namely, intestinal disorders, diarrhea and to re-equilibrate the intestinal bacterial flora, for the treatment of intestinal inflammations, inflammatory bowel diseases and inflammations of the lower gastrointestinal tract, for the treatment of ulcerative colitis and Crohn's disease in which inflammation is present both in the small intestine and in the colon; pharmaceutical products containing micro-organisms cultures, namely, lactic acid bacteria and bifidobacteria having probiotic activity on humans for the treatment of diseases, namely, intestinal disorders, diarrhea and to re-equilibrate the intestinal bacterial flora, for the treatment of intestinal inflammations, inflammatory bowel diseases and inflammations of the lower gastrointestinal tract, for the treatment of ulcerative colitis and Crohn's disease in which inflammation is present both in the small intestine and in the colon; pharmaceutical products, namely, probiotic lactic acid bacteria, probiotic bifidobacteria which are able to ferment and use the fibres in the human organism for the treatment of diseases, namely, intestinal disorders, diarrhea and to re-equilibrate the intestinal bacterial flora, for the treatment of intestinal inflammations, inflammatory bowel diseases and inflammations of the lower gastrointestinal tract, for the treatment of ulcerative colitis and Crohn's disease in which inflammation is present both in the small intestine and in the colon, and dietary and nutritional supplements containing microorganisms and cultures of microorganisms, namely, probiotic lactic acid bacteria, probiotic bifidobacteria which are able to ferment and use the fibres in the human organism; pharmaceutical products for oral consumption, namely, capsules, tablets, solutions, suspensions, granules, and pellets in dried form, containing micro-organisms cultures, namely, lactic acid bacteria and bifidobacteria having probiotic activity on humans for the treatment of diseases, namely, intestinal disorders, diarrhea and to re-equilibrate the intestinal bacterial flora, for the treatment of intestinal inflammations, inflammatory bowel diseases and inflammations of the lower gastrointestinal tract, for the treatment of ulcerative colitis and Crohn's disease in which inflammation is present both in the small intestine and in the colon, and dietary and nutritional supplements for oral consumption, namely, capsules, tablets, solutions, suspensions, granules, and pellets in dried form, containing micro-organisms cultures, namely, lactic acid bacteria and bifidobacteria having probiotic activity on humans; dietary supplements for medical use, namely metabolites obtained from the processing of probiotic bacterial cultures; probiotic and nutritional and dietary supplements; antifungal preparations; antifungal creams for medical use; vaginal antifungal preparations; fungal extracts sold as a component ingredient of nutritional supplements and vitamins and nutritional supplement for digestive health; nutritional supplement for combating digestive disorders such as Crohn's disease, ulcerative colitis and irritable bowel syndrome

Additional Information

Pseudo Mark
SLEEP BIOTICS

Classification

International Classes
005